Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rotarix®: vaccine performance 6 years postlicensure.

Expert review of vaccines - 1 Dec 2011

O'Ryan Miguel, Lucero Yalda, Linhares Alexandre C

Abstract excerpt

Rotarix(®) was first licensed in 2004 and rapidly introduced into private and public markets worldwide. In a previous 2009 article, we reviewed the impact of rotavirus-associated disease, the rationale for different vaccines, prelicensure efficacy studies and cost-effectiveness studies for Rotarix. As of September 2011, Rotarix had been licensed in 123 countries in the Americas, Europe, Australia, Africa and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diarrhea
Share to Global Health
Share to Immunization Programs

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Rotavirus

Share to Rotavirus Infections

Share to Rotavirus Vaccines

Share to Vaccination

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 22085167
DOI: 10.1586/erv.11.152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rotarix®: vaccine performance 6 years postlicensure.PMID 22085167Read ↗

Impact of rotavirus vaccines on rotavirus disease.Semantic proximity Read ↗

Dynamics of G2P[4] strain evolution and rotavirus vaccination: A review of evidence for Rotarix.Semantic proximity Read ↗

Rotavirus epidemiology before and after vaccine introduction.Semantic proximity Read ↗

The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix®Semantic proximity Read ↗

Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.Semantic proximity Read ↗

Rotavirus virus‐like particles (RV‐VLPs) vaccines: An updateSemantic proximity Read ↗

Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.Semantic proximity Read ↗

Vaccine-derived rotavirus strains in infants in England.Semantic proximity Read ↗

Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.Semantic proximity Read ↗

Rotavirus genotype diversity in Tanzania during Rotavirus vaccine implementation between 2013 and 2018.Semantic proximity Read ↗

Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?Semantic proximity Read ↗

Real-world impact of rotavirus vaccination.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.